New Zealand markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
28.36+0.62 (+2.24%)
At close: 04:00PM EDT
28.37 +0.01 (+0.04%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 160.70B
Enterprise value 217.48B
Trailing P/E N/A
Forward P/E 12.30
PEG ratio (5-yr expected) 1.00
Price/sales (ttm)2.92
Price/book (mrq)1.74
Enterprise value/revenue 3.96
Enterprise value/EBITDA 29.27

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-22.13%
S&P500 52-week change 324.43%
52-week high 337.80
52-week low 325.20
50-day moving average 327.63
200-day moving average 328.94

Share statistics

Avg vol (3-month) 338.56M
Avg vol (10-day) 334.21M
Shares outstanding 55.67B
Implied shares outstanding 65.67B
Float 85.66B
% held by insiders 10.05%
% held by institutions 168.53%
Shares short (15 May 2024) 470.22M
Short ratio (15 May 2024) 41.6
Short % of float (15 May 2024) 41.24%
Short % of shares outstanding (15 May 2024) 41.24%
Shares short (prior month 15 Apr 2024) 468.06M

Dividends & splits

Forward annual dividend rate 41.68
Forward annual dividend yield 45.92%
Trailing annual dividend rate 31.65
Trailing annual dividend yield 35.95%
5-year average dividend yield 44.06
Payout ratio 4443.24%
Dividend date 314 Jun 2024
Ex-dividend date 409 May 2024
Last split factor 21054:1000
Last split date 317 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -0.56%
Operating margin (ttm)31.63%

Management effectiveness

Return on assets (ttm)0.93%
Return on equity (ttm)-0.26%

Income statement

Revenue (ttm)54.89B
Revenue per share (ttm)9.72
Quarterly revenue growth (yoy)-19.50%
Gross profit (ttm)N/A
Net income avi to common (ttm)-288M
Diluted EPS (ttm)-0.05
Quarterly earnings growth (yoy)-43.80%

Balance sheet

Total cash (mrq)11.93B
Total cash per share (mrq)2.11
Total debt (mrq)69.9B
Total debt/equity (mrq)75.52%
Current ratio (mrq)1.05
Book value per share (mrq)16.28

Cash flow statement

Operating cash flow (ttm)8.58B
Levered free cash flow (ttm)3.46B